3-BrPA eliminates human bladder cancer cells with highly oncogenic signatures via engagement of specific death programs and perturbation of multiple signaling and metabolic determinants

BACKGROUND: Urinary bladder cancer is one of the most fatal and expensive diseases of industrialized world. Despite the strenuous efforts, no seminal advances have been achieved for its clinical management. Given the importance of metabolic reprogramming in cancer cell survival and growth, we have h...

Descripción completa

Detalles Bibliográficos
Autores principales: Konstantakou, Eumorphia G., Voutsinas, Gerassimos E., Velentzas, Athanassios D., Basogianni, Aggeliki-Stefania, Paronis, Efthimios, Balafas, Evangelos, Kostomitsopoulos, Nikolaos, Syrigos, Konstantinos N., Anastasiadou, Ema, Stravopodis, Dimitrios J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511243/
https://www.ncbi.nlm.nih.gov/pubmed/26198749
http://dx.doi.org/10.1186/s12943-015-0399-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511243/
https://www.ncbi.nlm.nih.gov/pubmed/26198749
http://dx.doi.org/10.1186/s12943-015-0399-9

Ejemplares similares